Real-world impact of glucocorticoid replacement therapy on bone mineral density: retrospective experience of a large single-center CAH cohort spanning 24 years
ConclusionsEven though a low CA regimen during growth periods in addition to MC replacement appears to have an influence on BMD at femoral sites, interestingly a low dexamethasone one does not seem to be deleterious for bone health in adulthood.
Source: Osteoporosis International - Category: Orthopaedics Source Type: research
More News: Congenital Adrenal Hyperplasia | Dexamethasone | Orthopaedics | Osteoporosis | PET Scan | Sodium Chloride | Study